Management of diabetes in pregnancy

25,703 views 88 slides Nov 25, 2017
Slide 1
Slide 1 of 88
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79
Slide 80
80
Slide 81
81
Slide 82
82
Slide 83
83
Slide 84
84
Slide 85
85
Slide 86
86
Slide 87
87
Slide 88
88

About This Presentation

Management of gestational diabetes mellitus


Slide Content

MANAGEMENT OF DIABETES IN PREGNANCY Sharon Treesa Antony 2 nd M.Sc Nursing Govt. College of Nursing, Kottayam

definition Diabetes mellitus is a metabolic disorder consequent to decrease in insulin secretion or increase in insulin resistance or both resulting in abnormalities of carbohydrate , protein and lipid metabolism.

Carbohydrate metabolism in pregnancy Diabetogenic state Insulin resistance HPL Cortisol , estriol , progesterone Insulin destruction by kidney and placental insulinases Increased lipolysis Changes in gluconeogenesis

Classification of pregnant patients with diabetes mellitus Pregestational Type 1 Type 2 Secondary Gestational Impaired glucose tolerance ( OGTT at 2 hour 140-199 mg/dl )

Modified white’s classification ( ACOG) CLASS Onset FBS 2 HOUR PPBS THERAPY A1 Gestational < 105 mg/dl <120 mg/dl Diet A2 > 105 >120 Insulin CLASS AGE OF ONSET DURAATION ( YEAR) VASCULAR DISEASE THERAPY B >20 YEARS <10 None Insulin C 10-19 10-19 None “ D <10 >20 Benign retinopathy “ F Any Any Nephropathy “ R Any Any Proliferative retinopathy “ H Any Any Heart “ T Any any Prior renal transplant t “

causes Type 1 – autoimmune, chromosome 6 and 11 Type 2 – insulin resistance, islet dysfunction

Risk factors for GDM Family history Previous overweight baby Previous IUD with pancreatic islet cell hyperplasia Unexplained perinatal loss Presence of polyhydramnios or recurrent vaginal candidiasis Persistent glycosuria

Age > 30 years Obesity Ethnic group ( East Asian, Pacific island)

Signs and symptoms Signs of GDM in previous pregnancy Infant > 4 kg IUD/Congenital anomalies Poly hydarmnios Recurrent monilial vaginitis

Signs of GDM in current pregnancy Glycosuria on 2 successive visits Recurrent monilial vaginitis Macrosomic baby Poly hydramnios

Pregestational diabetes mellitus Acanthosis nigricans T1 : hypogycemia , starvation leads to ketosis T2: hyperglycemia leading to ketonemia , aminoacidemia T3 : hypoglycemia , ketosis

Labour: hypoglycemia , acidemia from starvation ketosis Postpartum: hypoglycemia

ketoacidosis Hyperventilation Mental lethargy Dehydration Hypotension Abdominal pain, nausea, vomiting Fruity odour to breath Ketonuria

Screening and diagnosis Criteria for diagnosis of DM( expert committee 2001) Fasting plasma glucose >/=126 mg/dl 2 hour PPPG: >200mg/dl after a75g glucose load Symptoms of diabetes such as polyuria , polydypsia , unexplained weight loss + casual plasma glucose > 200 mg/dl

Gestational DM Low risk group <25 years Normal body weight prior to pregnancy Negative family history No h/o impaired glucose tolerance No h/o poor obstetric outcome Not a member of high risk ethnic group

High risk group + ve family history h/o poor obstetric outcome Prior infant> 4kg Obesity Multiple pregnancy PCOS

Glycosuria on 2 consecutive visits High risk ethnic group Hypertensive disorder Recurrent monilial vaginitis Poly hydramnios

All the high risk group should be screened at First visit Between 24-28 weeks

Two step approach 50g oral glucose 1 hour PPBS >130mg /dl OGTT

One step approach TIME CARPENTER AND COUSTAN ( mg/dl) NDDG FASTING 95 105 1 HOUR 180 190 2 HOURS 155 165 3 HOURS 140 145

PLASMA ( mg%) Time Normal tolerance Impaired glucose tolerance Diabetes Fasting < 100 >/= 100 and< 126 >/= 126 2 hour post glucose < 140 >/=140 and < 200 >/ = 200

IADPSG 2 PHASE STRATEGY FOR SCREENING OF DIABETES MELLITUS ( international association of diabetes & pregnancy study group) First antenatal visit :all women FBS/RBS/HbA1c FBS: >/= 126 mg% RBS: >/= 200mg% HbA1c:>/=6.5% OVERT DM

FBS: < 92mg% - normal >/= 92 mg% - GDM

24-28 WEEKS : OGTT All women not previously found to have GDM FBS: >/= 92mg% 1hour: >/= 180 mg% 2 hour: >/= 153mg% FBS: >/=126 mg%- overt DM All values< threshold is normal One or more values more than threshold: GDM

Effects of pregnancy on diabetes More insulin demand Hyperglycemia , ketoacidosis Hypoglycemia Progression of diabetic retinopathy Worsening of diabetic retinopathy Diabetic neuropathy Atherosclerosis More metabolic demands Insulin resistance

Effects of diabetes on pregnancy Spontaneous abortion Pre eclampsia Pre term labour Polyhydramnios Infection

Diabetic ketoacidosis Increased operative delivery PPH Pelvic floor trauma Retinopathy Hypoglycemia Prolongation of labour Shoulder dystocia

FETAL AND NEONATAL EFFECTS Hypoglycemia Hyperglycemia Congenital defects Macrosomia Growth restriction Fetal death

Neonatal complications Hypoglycemia Respiratory distress syndrome Hyperbilirubinemia Polycythemia Hypocalcemia Hypomagnesimia Cardiomyopathy

Long term effects Childhood obesity Neuropsychological effects Diabetes

management PRECONCEPTIONAL COUNSELLING

High risk case Regular follow up Evaluation of end organ damage at first visit

Diabetic nephropathy 24 hour urine protein Creatinine clearance BUN Urine culture

Retinopathy : fundus examination Cardiovascular system BP ECG Echocardiography Stress test Autonomic dysfunction

Good glycemic control ( HbA1c 4-6%) Start insulin for those on OHA Weight management, Exercise No smoking and alcohol Folic acid: 5mg/day

MANAGEMENT DURING PREGNANCY

Early registration Regular antenatal checkup At first visit: Evaluation for endorgan dysfunction Macrovascular disease Treat CAD TFT Advise SMBG 4-6 times/day

Metabolic goal during pregnancy Premeal plasma blood glucose : 70 – 105 mg/dl PPBS: no higher than 130mg/dl Monitor HbA1c every 4-6 weeks

Dietary therapy Consultation with dietician 30-35kcal/kg/day in the form of 3 major meals and 2-3 minor meals

CHO: 50-60% Fat :<30% Adequate fiber Protein: 12-20%

According to apa daily calorie intake <80% of ideal body weight: 36-40 kcal/kg 80-120%: 30 120-150: 24 >150: 12-18

Ideal body weight 100lb for first 5 feet height + 5 pounds/ inch for each inch over 5 feet (+ 10% for large frame)( - 10% for small frame)

Formula for calculating caloric needs Baseline calories= IBW* 10 Activity calories Sedentary: IBW* 3 Moderate: IBW* 5 Strenuous:(IBW*7)-10 Obesity: - 500 calories Pregnancy:+300 calories

Total calories= baseline calories+activity calories- obesity+ pregnancy

Calorie distribution( ACOG) 10-20% at breakfast 5-10% at midmorning 20-30% at lunch 5-10% at mid after noon snack 30-40% at dinner 5-10% at bed time snack

Low glycemic index foods and soluble fibres Lipids from monounsaturated fats: avacadoes , olive, peanut PUFA Limit sugary and concentrated sweets Plenty of cabbage, cucumber, green onions, mushrooms, spinach

One glass water/ hour Soluble and insoluble fiber Sodium: 3000mg/day

Meal plan Exchange system Carbohydrate counting Food pyramid

Lifestyle modifications Regular exercise Water intake Exercising site of injection Aerobic exercise with resistance training 2 times a week

Oral hypoglycemic agents Sulphonylureas Eg : Glyburide Increase insulin secretion 2.5mg PO daily

Biguanides Eg : metformin Cross placenta Transferred in breast milk

Thiazoledinediones Crosses placenta

Insulin therapy Short acting( regular) Rapid acting( lispro , aspart , glulisine ) Long acting ( NPH, lente , ultralente ) Mixtard (30/70)

Types of insulin Types Onset of action Peak of action ( hour) Duration of action (hour) RAPID ACTING Lispro <0.25 0.5-1.5 3-4 Insulin aspart <0.25 0.5-1.5 3-4 SHORT ACTING Regular 0.5-1.0 2-3 3-6 INTERMEDIATE ACTING NPH 2-4 6-10 10-16 Lente 3-4 6-12 12-18 COMBINATIONS 70/30 0.5-1 Dual 10-16 50/50 0.5-1 Dual 10-16

Calculation guidelines foor insulin during pregnancy Trimester Insulin dosage(unit/kg body weight Pre pregnant 0.5-0.6 T1 0.7-0.8 T2 0.8-1.0 T3 UNTIL 36 WEEKS 0.9-1.2 Post partum 0.6

Early morning Hyperglycemia causes Somogyi effect Dawn phenomenon Waning insulin

Insulin therapy for gDM When to initiate When MNT with exercise doesnot keep FPG< 95mg/dl 2 hour post prandial < 120 mg/dl

Fetal surveillance Detection of embryopathy 8-10 weeks: USG 10-12 weeks: HbA1c 16-20 weeks: maternal serum AFP genetic testing 18-20 weeks: anomaly scan 24-26 weeks:fetal echo

Growth monitoring SFH USG Q4weeks from 20 weeks

Assessment of fetal distress Twice weekly NST or weekly BPP from 28- 34 weeks Uterine artery doppler Amniocentesis for L/S ratio

Maternal surveillance with pre existing diabetes HbA1c every 4-6 weeks GRBS every visit urinalysis RFT with total protein, 24 hour urine protein, creatinine clearance Retinal examination TFT

Management of DKA Hydration:1L NS in 1 st hr, then 200-500ml/hr Insulin:10-20u PI IV bolus,5-10u/hr ( 50u in 500ml NS) Monitor blood glucose Q1-2 hours Glucose < 250 mg/dl: 5% D 5-10g/hr Potassium correction: after initial litre of fluid, KCL added in each pint Sodium bicarbonate:pH <7.1: 44mEq Q2H Monitoring

Management of preterm labour Nifedipine Steroid

Obstetric management Timing of delivery Mode Indications for CS Weight>/= 4500g Proliferative retinopathy Other associated indications Unstable IDDM

INTRAPARTUM MANAGEMENT Monitoring blood glucose, urine ketones To mainain RBS 72-144 mg/dl Planned CS Early morning, take night dose of insulin NPO& skip morning dose of insulin 5% neutralised with insulin( 6u / 500ml)

Infusion rate Blood sugar value Infusion rate 70-130 1u/hr 130-160 2u/hr 160-200 3u/hr

Postpartum care and advice Hydration GRBS Q2H Target FES:100mg/dl PPBS: 150mg/dl Diet control for type 2 DM OHA v/s insulin Metformin : hypoglycemia

OGTT at 6 weeks Recurrence in 50% Weight management Diet modification

contraception no OCP for those with vascular disease

Neonatal management Monitor for hypo glycemia , hypocalcemia , hypomagnesimia , hyperbilirubinemia and birth injury Early breast feeding Monitoring Hypoglycemia : 10% D IV 2ml/kg over 2-3 minutes

Nursing management Prevention Preconception Euglycemia History Physical examination Psychosocial Lab evaluation Educate about interaction between pregnancy, DM, family planning

7. Education in self management Diet Exercise SMBG Stress control Insulin administration GRBS Q1-2H after meals and at bed time HbA1c Q4-6 weeks Record keeping

During pregnancy Early confirmation of pregnancy HbA1c Q2-3 mon Dietary advices Consistent CHO intake No saturated fat and sugary foods Eat at same time each day Healthy snacks Water :8-10 glass /day

Sleep and rest Exercise Regular exercise Hydration Check blood glucose before and after exercise Carry a snack Aerobic exercise 30 minutes twice weekly Proper shoes ID bracelet

Coping Stress and fear More frequent prenatal visits Periodic USG, DFMC

Insulin administration Need for refrigeration reuse of syringes Rotation of injection sites

smbg After each meal Fasting Immediately after meals 1-2 hours after meals At bed time Between 2am and 3am

hypoglycemia Teach 15: 15 rule Have 15 g fast sugar Wait for 15 minutes Check again 15g CHO: glucose tablets, ½ cup orange juice, 1 cup skim milk, 5-6 hard candies

Sick day rules If unable to eat, continue insulin and GRBS and ketone monitoring Indications for calling doctor Insulin is usually doubled when urine ketones are present CHO food choices: lemon soda, orange juice Sodium and pottasium replacement Small amounts of fluids every hour Report vomiting

Intrapartum Preterm labor Insulin requirement falls Glucse requirement: 2.5mg/kg GRBS Q1-2 H IV infusion of D5 LR unless urine ketone present or blood glucose< 70mg/dl Insulin solution 25 units PI in 250ml NS

Insulin dosage PLASMA CAPILLARY BLOOD GLUCOSE ( mg/dl) INSULIN DOSAGE (units/hour) < 80 0.0 80-100 0.5 101-140 1.0 141-180 1.5 181-220 2.0 Greater than 220 2.5

Keep 50%D at bedside No breakfast and morning dose NPO

Continuous fetal monitoring Monitor labour progress V/S, input and output Urine ketones Complications

Caesarean delivery Timing no breakfast NPO GRBS Q1H Short acting insulin + glucose After delivery IV D5W 100-125ml/hour No insulin may be needed after delivery of placenta

Post partum ( type 1 and 2) Insulin If PPBS> 150 mg/dl, dosage of insulin 0.6 units/kg/hour Education to maintain euglycemia Encourage breast feeding +CHO snacks Dietary needs increases by 500-800 calories Fluctuations in blood glucose level Insulin does not cross the breast milk Monitor for breast infections

Postpartum ( GDm ) Monitor blood sugar 50% chance for type 2 DM OGTT at 6weeks and RBS / FBS annually Continue lifestyle modifications Family planning

Nursing diagnoses

THANK YOU